<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9E90A72A-4A7B-4D2D-854B-4DE60094219A"><gtr:id>9E90A72A-4A7B-4D2D-854B-4DE60094219A</gtr:id><gtr:name>St James's University Hospital (Jimmy's)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B8480401-8DDE-472E-9BFB-13DEC29BD816"><gtr:id>B8480401-8DDE-472E-9BFB-13DEC29BD816</gtr:id><gtr:name>Louisiana State University</gtr:name><gtr:address><gtr:line1>Louisiana State University</gtr:line1><gtr:line4>Baton Rouge</gtr:line4><gtr:line5>Louisiana</gtr:line5><gtr:postCode>LA 70803</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7D6D2169-850C-4CDC-B851-3A644DA28F85"><gtr:id>7D6D2169-850C-4CDC-B851-3A644DA28F85</gtr:id><gtr:name>University of Kentucky</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:department>Unknown</gtr:department><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9E90A72A-4A7B-4D2D-854B-4DE60094219A"><gtr:id>9E90A72A-4A7B-4D2D-854B-4DE60094219A</gtr:id><gtr:name>St James's University Hospital (Jimmy's)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B8480401-8DDE-472E-9BFB-13DEC29BD816"><gtr:id>B8480401-8DDE-472E-9BFB-13DEC29BD816</gtr:id><gtr:name>Louisiana State University</gtr:name><gtr:address><gtr:line1>Louisiana State University</gtr:line1><gtr:line4>Baton Rouge</gtr:line4><gtr:line5>Louisiana</gtr:line5><gtr:postCode>LA 70803</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7D6D2169-850C-4CDC-B851-3A644DA28F85"><gtr:id>7D6D2169-850C-4CDC-B851-3A644DA28F85</gtr:id><gtr:name>University of Kentucky</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1F69FD35-4D3A-4A81-8A50-D5A2ABF41D71"><gtr:id>1F69FD35-4D3A-4A81-8A50-D5A2ABF41D71</gtr:id><gtr:firstName>Claire</gtr:firstName><gtr:otherNames>Ritchie</gtr:otherNames><gtr:surname>Chalmers</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G84%2F6469"><gtr:id>278A8E4F-B46B-4044-A369-6228DFD3FFE8</gtr:id><gtr:title>The anti-angiogenic activity of the selective cyclooxygenase-2 inhibitor rofecoxib on colorectal cancer liver metastases</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G84/6469</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-10-03</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>138674</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>St James's University Hospital (Jimmy's)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Hepatobiliary, Medical Physics and Radiology Units</gtr:department><gtr:description>Hepatobiliary, Medical Physics and Radiology Units at St James's University Hospital</gtr:description><gtr:id>E8C018F2-2403-4A2B-80BF-4E6CA9E8B447</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>Wznc9Bj5Vzc-1</gtr:outcomeId><gtr:partnerContribution>access to patients undergoing assessment and treatment for CRC liver metastases and to facilities such as fresh specimen collection and dynamic contrast-enhanced MRI scanning. The Cancer Research UK Clinical Research Centre on campus provided access to resources including radio-isotope measurement.</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kentucky</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Professor Tai (Dept of Pharmaceutical Sciences, University of Kentucky, Lexington, KY, USA).</gtr:description><gtr:id>594899E9-47EB-488D-993C-96F16486B313</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>eR44bY8x6N2-1</gtr:outcomeId><gtr:partnerContribution>obtained information and reagents from Professor Tai</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Louisiana State University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Surgical Endocrinology/Oncology</gtr:department><gtr:description>Dr Woltering (Dept of Surgical Endocrinology, Louisiana State University, New Orleans, USA)</gtr:description><gtr:id>892D8C5A-12C8-4779-9050-7CB25818D17C</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>Ydqzig4zk9t-1</gtr:outcomeId><gtr:partnerContribution>obtained information and reagents from Dr Woltering</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B1E230F3-A083-4CD0-B8B3-F7CA06FBFF79</gtr:id><gtr:title>Antiangiogenic activity of the selective cyclooxygenase 2 inhibitor rofecoxib in human colorectal cancer liver metastases.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8d8fa93fd754f5d7048f4b62353e9c5"><gtr:id>a8d8fa93fd754f5d7048f4b62353e9c5</gtr:id><gtr:otherNames>Chalmers CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>iAGusWSNgop</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5ED93E1C-FF52-41F4-BBFE-CDB79A1486EE</gtr:id><gtr:title>Immunohistochemical measurement of endothelial cell apoptosis and proliferation in formalin-fixed, paraffin-embedded human cancer tissue.</gtr:title><gtr:parentPublicationTitle>Angiogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8d8fa93fd754f5d7048f4b62353e9c5"><gtr:id>a8d8fa93fd754f5d7048f4b62353e9c5</gtr:id><gtr:otherNames>Chalmers CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0969-6970</gtr:issn><gtr:outcomeId>deEVPNShwF5</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G84/6469</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>